Seagen
Breakthrough Properties Acquires Stalled Seagen Biologics Plant in Everett for $78MM
A biomanufacturing facility that Pfizer abandoned two years into a $500 million build-out has changed hands for a fraction of that investment, landing...
Immunome Expands at Alloy Innovation Center with 13,000 SQFT in Bothell Ahead of FDA Decision
Oncology company Immunome has added 13,346 square feet at 11804 North Creek Parkway, expanding within the same Bothell campus where it established its...
BioLife Solutions Converts Former Bothell Church Into 5,000 SQFT Cryobiology Lab, Pushing Footprint to 64,000 SQFT
A onetime evangelical sanctuary on Monte Villa Parkway has been gutted and rebuilt into one of the few dedicated cryobiology research labs in...
Bothell’s Biotech Blues: A Life Sciences Hub Under Pressure
A string of facility closures and workforce cuts threatens the Seattle suburb’s ambitions to become a major biotech center The signs of distress...
Curi Bio Signs 14,000 SQFT Lease at BioMed Realty’s 201 Elliott Avenue West in Seattle
BioMed Realty, a Blackstone portfolio company specializing in real estate solutions for the life science and technology sectors, has announced today the signing...
Pfizer Halts $350MM Manufacturing Facility in Everett, Lays Off 120
In a surprising move, Pfizer Inc. (NYSE: PFE), a leading global pharmaceutical company, has announced it is stopping its ambitious $350 million manufacturing...
Following Merger with East Coast Firm, Biotech Firm Decides to Locate HQ in Seattle
By The Registry Staff Clay Siegall, the co-founder and former CEO of Bothell-based biotech Seagen, is currently leading a new biotech venture through...
Seagen Plans to Develop 270,000 SQFT Biomanufacturing Facility in Everett
– New 270,000-square-foot facility in Everett, Washington, is expected to enhance scientific manufacturing capabilities and expand highly skilled workforce – BOTHELL, Wash.–Seagen Inc. (Nasdaq:...
